杨宁介入医学网

门静脉高压的分类 门静脉高压并发症的危险性，由于不同的门脉高压病因类型而不同，主要是取决于肝功能衰竭恶化效应。相对于对肝脏腺泡结构危害较小的情况，肝硬化或爆发性肝炎伴随发生时，其表现形式更为严重。因此，虽然有其他分类方法，将门脉高压分为 窦...

门静脉高压的名词和定义 由于门静脉自然引（回）流受阻而引起的一系列血流动力学改变和临床症状，称为门静脉高压症(Portal hypertension，PH)。门脉高压（PH）是一个综合征。在生理情况下，门脉血管和肝脏对门脉属支血流的阻力很小，在不明显改变门静脉压力...

Pre-sinusoidal 窦前性 Sinusoidal 窦性 Post-sinusoida l窦后性 Porto-sinusoidal vascular disease (PSVD) Drug-induced Budd-Chiari syndrome Portal vein obstruction (neoplastic and non-neoplastic) Alcoholic liver damage Veno-occlusive disease S...

Non-tumoral PVT is the most common thrombotic event in patients with cirrhosis, with an annual incidence of up to 12%[127,128]. 非肿瘤性PVT是肝硬化患者中最常见的血栓性事件，每年的发病率高达12%的[127,128]。 Asymptomatic presentation is commo...

Hepatic cirrhosis is a chronic disease histologically characterized by the presence of regenerative nodules surrounded by diffuse fibrosis(21). 肝硬化是一种慢性疾病，其组织学特征是弥漫性再生结节周围的纤维化（21）。 It is the common final s...

Acute variceal bleeding (AVB), which accounts for 70% of all upper gastrointestinal bleeding episodes in cirrhosis,[1] has been identified as a common cause of death in patients with cirrhosis, with a 6-week mortality around 20%. 急性静脉...

When to Suspect PSVD? 何时怀疑PSVD？ There are two clinical scenarios in whom PSVD can be suspected: patients with chronic and unexplained alteration of liver enzymes without portal hypertension and patients with unexplained clinically evi...

The term non-cirrhotic portal hypertension (NCPH) refers to a heterogeneous group of liver disorders that primarily affect the liver vascular system and that are classified anatomically on the basis of site of resistance to blood flow, as...

Porto sinusoidal vascular liver disease (PSVD) is a vascular liver disease characterized by portal hypertension in the absence of cirrhosis and other causes of liver disease[1]. 门窦性血管性肝病(PSVD)是一种以血管性肝病为特征的门静脉高压，...

发病机制 到目前为止，INCPH 的具体病理生理机制尚不 明确。分二元理论和统一理论 二元理论： 认为，肝内血管闭塞所致 门静脉血流阻力增加和脾大继发门静脉血流增加是 导致 INCPH 患者门静脉高压的两个主要因素。肝 内血管闭塞的具体原因尚不清楚 统一理论：...